National wastewater surveillance system multi-pathogen assay development, optimization, validation, and support
Active Definitive Contract Awarded Last action
- Contract number
- 75D30124C19209
- Awardee
-
GT Molecular, Inc. UEI DKH3J319XJL6
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,029,779
Award facts
- Opportunity
-
- National Wastewater Surveillance System Multi-Pathogen Assay Development, Optimization, Validation, and Support Solicitation · 75D30124R73073 · Posted Jul 23, 2024
- Contract value 62% obligated
-
- $1,029,779.00 Current, with exercised options
- $1,665,445.00 Potential, with all options
- Completion date 42% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Time and Materials
- Place of performance
- Atlanta, GA 30329, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $311,684 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $299,386 | |
| Original award | $418,709 |
About this award
The Centers for Disease Control and Prevention awarded a $1,665,445 definitive contract to GT Molecular, Inc. for development, optimization, and validation of digital PCR-based multi-pathogen assays supporting the National Wastewater Surveillance System on September 3, 2024, under a total small business set-aside. GT Molecular is a minority-owned, self-certified small disadvantaged business.
The originating solicitation sought assay development and validation services to support NWSS interrogation of wastewater for multiple pathogens, antimicrobial resistance, and vector targets using digital PCR platforms. Place of performance is Atlanta, GA. The contract carries a 12-month base period and four 12-month option periods, with an ultimate completion date of September 2, 2029.
Pricing is time and materials. In FY2024, the contract invoiced $20 thousand across 50 contractor hours at a derived rate of $408.73 per hour, with self-performance by the prime and no subcontractors reported.
Quick answers
Who was awarded contract 75D30124C19209?
75D30124C19209 was awarded to GT Molecular, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 3, 2024.
How much is contract 75D30124C19209 worth?
The government has obligated $1,029,779 on 75D30124C19209. Its potential value, with all options, is $1,665,445.
Was contract 75D30124C19209 competed?
The extent of competition for 75D30124C19209 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award